Insider Buying: Fusion Antibodies plc (LON:FAB) Insider Purchases £3,600 in Stock

Fusion Antibodies plc (LON:FAB) insider Adrian Kinkaid acquired 120,000 shares of the business’s stock in a transaction dated Wednesday, September 4th. The shares were bought at an average price of GBX 3 ($0.04) per share, with a total value of £3,600 ($4,733.73).

Fusion Antibodies Price Performance

Shares of Fusion Antibodies stock opened at GBX 3.30 ($0.04) on Friday. Fusion Antibodies plc has a 12-month low of GBX 2.80 ($0.04) and a 12-month high of GBX 9.50 ($0.12). The firm has a market capitalization of £3.15 million, a PE ratio of -82.50 and a beta of 0.48. The company has a quick ratio of 2.36, a current ratio of 3.26 and a debt-to-equity ratio of 3.23. The stock’s fifty day moving average is GBX 3.21 and its 200-day moving average is GBX 3.52.

About Fusion Antibodies

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services.